Randomized controlled trial with two parallel branches (experimental product and placebo), double blind and unicentric with which it is intended to evaluate the efficacy of the product under investigation against placebo on blood pressure of normotensive subjects or with hypertension grade I without Pharmacotherapy. The subjects that meet the selection criteria will make a total of five visits to the research laboratory and perform the tests that were pre-established in the protocol. Later, a statistical analysis will be carried out with the variables measured in the study to obtain results.

Inclusion Criteria:

• Subjects of both sexes between 18-65 years old.
• Systolic blood pressure between 120 and 159 mmHg or diastolic blood pressure between 80 and 100 mm Hg. taken in basal conditions.
• Volunteers able to understand the clinical study and willing to comply with the procedures and requirements of the study

Exclusion Criteria:

• In pharmacological treatment of arterial hypertension.
• Subjects with acute diseases.
• Volunteers with a history or presence of chronic pulmonary, hepatic, renal, hematological, gastrointestinal, endocrine, immunological, dermatological, urological, neurological, psychiatric, cardiovascular or pathological conditions or malignant tumor disease that can modify the blood pressure of subjects.
• Subjected to major surgery in the last 3 months.
• Subjects who stopped smoking in the last 6 months or who intend to quit during the study.
• Subjects with allergies or eating disorders.
• Participation in another study that includes blood extractions or dietary intervention.
• Pregnant woman.
• Subjects whose condition does not make them eligible for the study, according to the researcher.